Reference : Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after inducti...
Scientific journals : Article
Human health sciences : Hematology
http://hdl.handle.net/2268/12369
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia : final results of AML-13, a randomized phase-3 study
English
Amadori, Sergio [ > > ]
Suciu, Stefan [ > > ]
Jehn, Ulrich [ > > ]
Stasi, Roberto [ > > ]
Thomas, Xavier [ > > ]
Marie, Jean-Pierre [ > > ]
Muus, Petra [ > > ]
Lefrère, François [ > > ]
Berneman, Zwi [ > > ]
Fillet, Georges mailto [Université de Liège - ULg > Département des sciences cliniques > Hématologie - Oncologie médicale >]
Denzlinger, Claudio [ > > ]
Willemze, Roel [ > > ]
Leoni, Pietro [ > > ]
Leone, Giuseppe [ > > ]
Casini, Marco [ > > ]
Ricciuti, Francesco [ > > ]
Vignetti, Marco [ > > ]
Beeldens, Filip [ > > ]
Mandelli, Franco [ > > ]
de Witte, Theo [ > > ]
2005
Blood
106
27-34
Yes
http://hdl.handle.net/2268/12369

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
214.pdfPublisher postprint277.39 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.